JGC
CNMD icon

J. Goldman & Co’s CONMED CNMD Stock Holding History

J. Goldman & Co’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19,098
Closed -$2.14M – 259
2019
Q4 		$2.14M Sell
19,098
-77,759
-80% -$8.29M 0.15% 129
2019
Q3 		$9.31M Sell
96,857
-65,914
-40% -$6.19M 0.7% 46
2019
Q2 		$13.9M Buy
162,771
+39,866
+32% +$3.28M 0.97% 27
2019
Q1 		$10.2M Buy
+122,905
New +$8.93M 0.58% 49
2015
Q3 		– Sell
-45,654
Closed -$2.66M – 231
2015
Q2 		$2.66M Sell
45,654
-21,585
-32% -$1.16M 0.16% 142
2015
Q1 		$3.4M Sell
67,239
-22,761
-25% -$1.12M 0.21% 133
2014
Q4 		$4.05M Buy
90,000
+45,000
+100% +$1.89M 0.48% 66
2014
Q3 		$1.66M Buy
+45,000
New +$1.79M 0.1% 192

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

J. Goldman & Co's CNMD Position: Q1 2020 in Review

J. Goldman & Co sold out of CONMED (CNMD) in Q1 2020, closing a stake of 19,098 shares — an estimated $2.14M sold.

J. Goldman & Co first reported a position in CNMD in Q3 2014 and held it in 8 quarters. The position peaked at $13.9M in Q2 2019. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • J. Goldman & Co reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • J. Goldman & Co sold 19,098 CONMED shares in Q1 2020, an estimated $2.14M.
  • J. Goldman & Co first reported a position in CONMED in Q3 2014 and held it in 8 quarters.
  • J. Goldman & Co's CONMED position peaked at $13.9M in Q2 2019.
  • 228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on J. Goldman & Co's 13F filing for Q1 2020, filed 15 May 2020.